Tower Research Capital LLC (Trc) Ice Cure Medical Ltd. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 294 shares of ICCM stock, worth $320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294
Previous 294
-0.0%
Holding current value
$320
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ICCM
# of Institutions
16Shares Held
195KCall Options Held
0Put Options Held
0-
Ubs Group Ag59.9KShares$65,2840.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$28,6780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$27,8600.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$20,1920.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$15,8880.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $40.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.